Perdagangan Quince Therapeuticks Inc - QNCX CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
Spread | 0.0328 | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.024874% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | 0.002651% | ||||||||
Waktu biaya inap | 21:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | USD | ||||||||
Margin | 20% | ||||||||
Bursa efek | United States of America | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Key Stats
Prev. Close* | 1.5486 |
Open* | 1.4886 |
1-Year Change* | -75.76% |
Day's Range* | 1.4886 - 1.5586 |
52 wk Range | 0.54-6.80 |
Average Volume (10 days) | 5.96M |
Average Volume (3 months) | 47.40M |
Market Cap | 56.59M |
P/E Ratio | -100.00K |
Shares Outstanding | 36.28M |
Revenue | N/A |
EPS | -1.61 |
Dividend (Yield %) | N/A |
Beta | 1.38 |
Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 31, 2023 | 1.5486 | 0.0600 | 4.03% | 1.4886 | 1.5686 | 1.4886 |
Mar 30, 2023 | 1.5486 | 0.0500 | 3.34% | 1.4986 | 1.5686 | 1.4886 |
Mar 29, 2023 | 1.5386 | 0.0499 | 3.35% | 1.4887 | 1.5686 | 1.4687 |
Mar 28, 2023 | 1.4687 | 0.0100 | 0.69% | 1.4587 | 1.5186 | 1.4487 |
Mar 27, 2023 | 1.4487 | 0.0200 | 1.40% | 1.4287 | 1.5486 | 1.4287 |
Mar 24, 2023 | 1.4587 | 0.0600 | 4.29% | 1.3987 | 1.4787 | 1.3488 |
Mar 23, 2023 | 1.3588 | -0.0899 | -6.21% | 1.4487 | 1.4687 | 1.3488 |
Mar 22, 2023 | 1.4187 | 0.0200 | 1.43% | 1.3987 | 1.4687 | 1.3688 |
Mar 21, 2023 | 1.4187 | 0.0000 | 0.00% | 1.4187 | 1.5186 | 1.3388 |
Mar 20, 2023 | 0.8196 | 0.0004 | 0.05% | 0.8192 | 0.8360 | 0.7892 |
Mar 17, 2023 | 0.8188 | -0.0171 | -2.05% | 0.8359 | 0.8359 | 0.7848 |
Mar 16, 2023 | 0.8193 | -0.0066 | -0.80% | 0.8259 | 0.8557 | 0.7919 |
Mar 15, 2023 | 0.8410 | -0.0382 | -4.34% | 0.8792 | 0.8792 | 0.8155 |
Mar 14, 2023 | 0.8716 | -0.0339 | -3.74% | 0.9055 | 0.9155 | 0.8691 |
Mar 13, 2023 | 0.8791 | -0.0663 | -7.01% | 0.9454 | 0.9454 | 0.8656 |
Mar 10, 2023 | 0.9237 | -0.0326 | -3.41% | 0.9563 | 0.9752 | 0.9237 |
Mar 9, 2023 | 0.9743 | -0.0247 | -2.47% | 0.9990 | 1.0490 | 0.9643 |
Mar 8, 2023 | 0.9832 | 0.0080 | 0.82% | 0.9752 | 0.9950 | 0.9393 |
Mar 7, 2023 | 0.9591 | 0.0079 | 0.83% | 0.9512 | 0.9784 | 0.9491 |
Mar 6, 2023 | 0.9667 | 0.0023 | 0.24% | 0.9644 | 0.9868 | 0.9433 |
Quince Therapeuticks Inc Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 |
Total Operating Expense | 52.015 | 90.318 | 78.893 | 39.168 | 12.119 |
Selling/General/Admin. Expenses, Total | 26.012 | 29.523 | 17.586 | 8.954 | 2.034 |
Research & Development | 25.178 | 60.795 | 61.307 | 30.214 | 10.085 |
Operating Income | -52.015 | -90.318 | -78.893 | -39.168 | -12.119 |
Interest Income (Expense), Net Non-Operating | 1.068 | 0.62 | 2.044 | 2.188 | -0.357 |
Net Income Before Taxes | -51.944 | -89.945 | -76.849 | -36.98 | -12.476 |
Net Income After Taxes | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
Net Income Before Extra. Items | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
Total Extraordinary Items | |||||
Net Income | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
Income Available to Common Excl. Extra. Items | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
Income Available to Common Incl. Extra. Items | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
Diluted Net Income | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
Diluted Weighted Average Shares | 33.4965 | 29.7185 | 29.1762 | 19.0319 | 26.0133 |
Diluted EPS Excluding Extraordinary Items | -1.54225 | -3.02657 | -2.63396 | -1.94305 | -0.4796 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
Diluted Normalized EPS | -1.52624 | -3.02657 | -2.63396 | -1.94305 | -0.4796 |
Other, Net | -0.997 | -0.247 | |||
Unusual Expense (Income) | 0.825 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 |
Total Operating Expense | 6.319 | 7.62 | 16.258 | 21.863 | 23.544 |
Selling/General/Admin. Expenses, Total | 3.551 | 4.344 | 9.059 | 9.106 | 8.331 |
Research & Development | 2.768 | 2.451 | 7.199 | 12.757 | 15.213 |
Operating Income | -6.319 | -7.62 | -16.258 | -21.863 | -23.544 |
Interest Income (Expense), Net Non-Operating | 0.536 | 0.315 | 0.145 | 0.072 | 0.105 |
Net Income Before Taxes | -5.534 | -7.921 | -16.848 | -21.641 | -23.399 |
Net Income After Taxes | -5.534 | -7.921 | -16.564 | -21.641 | -23.399 |
Net Income Before Extra. Items | -5.534 | -7.921 | -16.564 | -21.641 | -23.399 |
Net Income | -5.534 | -7.921 | -16.564 | -21.641 | -23.399 |
Income Available to Common Excl. Extra. Items | -5.534 | -7.921 | -16.564 | -21.641 | -23.399 |
Income Available to Common Incl. Extra. Items | -5.534 | -7.921 | -16.564 | -21.641 | -23.399 |
Diluted Net Income | -5.534 | -7.921 | -16.564 | -21.641 | -23.399 |
Diluted Weighted Average Shares | 35.7117 | 35.6128 | 32.467 | 30.1345 | 29.962 |
Diluted EPS Excluding Extraordinary Items | -0.15496 | -0.22242 | -0.51018 | -0.71815 | -0.78095 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Diluted Normalized EPS | -0.15496 | -0.19925 | -0.51018 | -0.71815 | -0.78095 |
Other, Net | 0.249 | -0.616 | -0.735 | 0.15 | 0.04 |
Unusual Expense (Income) | 0 | 0.825 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Current Assets | 111.673 | 137.862 | 106.056 | 72.584 | 7.537 |
Cash and Short Term Investments | 106.802 | 133.82 | 99.864 | 71.716 | 7.343 |
Cash | 40.27 | 35.69 | 4.074 | 11.259 | 7.343 |
Cash & Equivalents | 15.954 | 16.151 | 46.155 | 11.815 | 0 |
Short Term Investments | 50.578 | 81.979 | 49.635 | 48.642 | 0 |
Prepaid Expenses | 3.376 | 3.348 | 5.504 | 0.766 | 0.141 |
Other Current Assets, Total | 1.495 | 0.694 | 0.688 | 0.102 | 0.053 |
Total Assets | 133.228 | 189.466 | 124.37 | 72.877 | 7.718 |
Property/Plant/Equipment, Total - Net | 1.428 | 1.101 | 1.334 | 0.283 | 0.122 |
Property/Plant/Equipment, Total - Gross | 2.387 | 1.716 | 1.617 | 0.378 | 0.166 |
Accumulated Depreciation, Total | -0.959 | -0.615 | -0.283 | -0.095 | -0.044 |
Other Long Term Assets, Total | 0.194 | 0.039 | 0.217 | 0.01 | 0.059 |
Total Current Liabilities | 14.222 | 16.996 | 8.892 | 1.457 | 1.763 |
Accounts Payable | 4.911 | 3.555 | 3.075 | 0.495 | 0.517 |
Accrued Expenses | 9.311 | 13.441 | 5.817 | 0.962 | 1.246 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 14.642 | 17.204 | 8.892 | 1.457 | 10.82 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 7.171 |
Long Term Debt | 0 | 7.171 | |||
Other Liabilities, Total | 0.42 | 0.208 | 0 | 1.886 | |
Total Equity | 118.586 | 172.262 | 115.478 | 71.42 | -3.102 |
Redeemable Preferred Stock | 0 | 104.046 | 17.178 | ||
Common Stock | 0.03 | 0.029 | 0.027 | 0.009 | 0.009 |
Additional Paid-In Capital | 355.234 | 318.574 | 185.196 | 0.239 | 0.06 |
Retained Earnings (Accumulated Deficit) | -236.599 | -146.654 | -69.805 | -32.825 | -20.349 |
Other Equity, Total | -0.079 | 0.313 | 0.06 | -0.049 | 0 |
Total Liabilities & Shareholders’ Equity | 133.228 | 189.466 | 124.37 | 72.877 | 7.718 |
Total Common Shares Outstanding | 30.0744 | 29.5432 | 26.8694 | 26.0133 | 26.0133 |
Long Term Investments | 19.933 | 50.464 | 16.763 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Current Assets | 96.353 | 111.673 | 119.427 | 135.843 | 149.885 |
Cash and Short Term Investments | 91.524 | 106.802 | 114.412 | 129.95 | 147.035 |
Cash | 27.403 | 40.27 | 8.357 | 5.744 | 24.569 |
Cash & Equivalents | 32.361 | 15.954 | 36.6 | 47.049 | 38.246 |
Short Term Investments | 31.76 | 50.578 | 69.455 | 77.157 | 84.22 |
Prepaid Expenses | 2.784 | 3.376 | 4.52 | 5.455 | 2.293 |
Other Current Assets, Total | 2.045 | 1.495 | 0.495 | 0.438 | 0.557 |
Total Assets | 116.13 | 133.228 | 147.416 | 161.39 | 174.522 |
Property/Plant/Equipment, Total - Net | 0.573 | 1.428 | 1.655 | 1.886 | 0.878 |
Property/Plant/Equipment, Total - Gross | 1.569 | 2.387 | 2.53 | 2.674 | 1.579 |
Accumulated Depreciation, Total | -0.996 | -0.959 | -0.875 | -0.788 | -0.701 |
Long Term Investments | 19.175 | 19.933 | 26.141 | 23.516 | 23.72 |
Other Long Term Assets, Total | 0.029 | 0.194 | 0.193 | 0.145 | 0.039 |
Total Current Liabilities | 9.71 | 14.222 | 14.154 | 18.537 | 17.867 |
Accounts Payable | 3.731 | 4.911 | 2.88 | 7.193 | 2.845 |
Accrued Expenses | 5.979 | 9.311 | 11.274 | 11.344 | 15.022 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 9.75 | 14.642 | 14.764 | 19.31 | 18.038 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 0.04 | 0.42 | 0.61 | 0.773 | 0.171 |
Total Equity | 106.38 | 118.586 | 132.652 | 142.08 | 156.484 |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.029 |
Additional Paid-In Capital | 365.096 | 355.234 | 345.751 | 333.427 | 326.006 |
Retained Earnings (Accumulated Deficit) | -258.24 | -236.599 | -213.2 | -191.494 | -169.74 |
Other Equity, Total | -0.506 | -0.079 | 0.071 | 0.117 | 0.189 |
Total Liabilities & Shareholders’ Equity | 116.13 | 133.228 | 147.416 | 161.39 | 174.522 |
Total Common Shares Outstanding | 30.1496 | 30.0744 | 29.8673 | 29.6558 | 29.5759 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
Cash From Operating Activities | -44.038 | -62.932 | -50.818 | -33.277 | -11.695 |
Cash From Operating Activities | 0.204 | 0.344 | 0.332 | 0.188 | 0.051 |
Non-Cash Items | 17.437 | 30.93 | 15.472 | 1.611 | 1.12 |
Cash Interest Paid | 0.001 | ||||
Changes in Working Capital | -9.735 | -4.261 | 10.227 | 1.904 | -0.39 |
Cash From Investing Activities | 18.002 | 58.952 | -52.431 | -17.747 | -46.754 |
Capital Expenditures | -0.133 | -0.18 | -0.052 | -0.055 | -0.212 |
Other Investing Cash Flow Items, Total | 18.135 | 59.132 | -52.379 | -17.692 | -46.542 |
Cash From Financing Activities | 0.707 | 6.808 | 118.876 | 77.366 | 75.928 |
Issuance (Retirement) of Stock, Net | 0.756 | 6.808 | 118.91 | 77.925 | 75.678 |
Issuance (Retirement) of Debt, Net | -0.049 | 0 | -0.034 | -0.559 | 0.25 |
Net Change in Cash | -25.145 | 2.883 | 15.627 | 26.342 | 17.479 |
Foreign Exchange Effects | 0.184 | 0.055 | |||
Deferred Taxes | -0.284 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -51.66 | -46.126 | -38.205 | -21.641 | -89.945 |
Cash From Operating Activities | -44.038 | -38.203 | -31.506 | -16.091 | -62.932 |
Cash From Operating Activities | 0.204 | 0.162 | 0.122 | 0.038 | 0.344 |
Non-Cash Items | 17.437 | 16.03 | 14.565 | 9.375 | 30.93 |
Changes in Working Capital | -9.735 | -7.985 | -7.704 | -3.863 | -4.261 |
Cash From Investing Activities | 18.002 | -0.664 | 8.162 | 13.413 | 58.952 |
Capital Expenditures | -0.133 | -0.055 | -0.005 | -0.005 | -0.18 |
Other Investing Cash Flow Items, Total | 18.135 | -0.609 | 8.167 | 13.418 | 59.132 |
Cash From Financing Activities | 0.707 | 0.725 | 0.73 | 0.622 | 6.808 |
Issuance (Retirement) of Stock, Net | 0.756 | 0.756 | 0.742 | 0.622 | 6.808 |
Net Change in Cash | -25.145 | -37.915 | -22.796 | -2.16 | 2.883 |
Issuance (Retirement) of Debt, Net | -0.049 | -0.031 | -0.012 | 0 | |
Foreign Exchange Effects | 0.184 | 0.227 | -0.182 | -0.104 | 0.055 |
Deferred Taxes | -0.284 | -0.284 | -0.284 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Lamond (David A.) | Individual Investor | 10.1543 | 3683658 | 1634720 | 2022-01-31 | |
Dominy (Stephen S) | Individual Investor | 3.9631 | 1437674 | 763 | 2022-01-31 | |
Lynch (Casey C) | Individual Investor | 3.2544 | 1180580 | -120000 | 2022-01-31 | |
EPIQ Capital Group, LLC | Investment Advisor | 2.9115 | 1056191 | -1000478 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 2.4701 | 896084 | -61145 | 2022-12-31 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.3524 | 853391 | -18615 | 2022-12-31 | LOW |
Pfizer Inc | Corporation | 1.6539 | 600000 | -1456377 | 2021-12-31 | MED |
Millennium Management LLC | Hedge Fund | 1.6424 | 595801 | 137810 | 2022-12-31 | HIGH |
Low (Philip S) | Individual Investor | 1.2551 | 455309 | 455309 | 2022-05-19 | |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.9169 | 332627 | -165208 | 2022-12-31 | LOW |
Thye (Dirk) | Individual Investor | 0.7744 | 280911 | 280911 | 2022-05-19 | |
Lowe (Christopher P) | Individual Investor | 0.7305 | 265000 | 175000 | 2022-03-03 | LOW |
Federated Hermes MDTA LLC | Investment Advisor/Hedge Fund | 0.6904 | 250458 | -264583 | 2022-12-31 | HIGH |
Smith (Karen L) | Individual Investor | 0.5367 | 194690 | 194690 | 2022-05-19 | LOW |
Alphabet, Inc. | Venture Capital | 0.5213 | 189122 | 0 | 2022-12-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.4248 | 154100 | -180125 | 2022-12-31 | HIGH |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 0.4239 | 153788 | 0 | 2022-12-31 | MED |
Holsinger (Leslie) | Individual Investor | 0.3985 | 144580 | -10920 | 2022-06-06 | |
Detke (Michael J) | Individual Investor | 0.3859 | 140000 | 140000 | 2022-03-03 | |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3779 | 137086 | -9128 | 2022-12-31 | LOW |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group500K+
Trader
92K+
Klien aktif per bulan
$53M+
Volume investasi per bulan
$30M+
Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Industry: | Biotechnology & Medical Research (NEC) |
269 East Grand Ave
94080
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com